What are the treatment options for Polycystic Ovary Syndrome (PCOS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Polycystic Ovary Syndrome (PCOS)

Lifestyle modification with multicomponent intervention (diet, exercise, and behavioral strategies) is the first-line treatment for all women with PCOS, regardless of weight or reproductive goals, followed by targeted pharmacotherapy based on whether pregnancy is desired. 1, 2

First-Line Treatment: Lifestyle Modification

All women with PCOS should begin with comprehensive lifestyle intervention before or alongside pharmacological treatment. 1

Weight Management

  • Target a 30% energy deficit or 500-750 kcal/day reduction for weight loss 2, 3
  • Even modest weight loss of just 5% of initial body weight significantly improves metabolic and reproductive abnormalities, including ovulation and pregnancy rates 3, 4
  • Weight loss improves insulin resistance, hyperandrogenism (measured by free androgen index), and BMI 5
  • Exercise shows positive effects even without weight loss, so physical activity should be emphasized regardless of weight changes 3

Exercise Recommendations

  • Both aerobic and resistance exercise enhance insulin sensitivity, promote weight loss, and improve metabolic and reproductive outcomes 4
  • Exercise improves the free androgen index independent of weight changes 5

Dietary Approaches

  • No specific diet is superior; focus on caloric restriction and healthy eating patterns 1
  • Evidence supports: low glycemic index foods, high-fiber diets, omega-3 fatty acid-rich diets, ketogenic diets, Mediterranean diets, and anti-inflammatory diets 4
  • All dietary approaches work primarily through improving insulin sensitivity and hormonal balance 4

Behavioral Strategies

  • Include education modules, adherence support, and mental health management 1
  • Address depression, anxiety, and eating disorders, which occur at higher rates in PCOS patients 2

Treatment Based on Reproductive Goals

For Women NOT Attempting Pregnancy

Combined oral contraceptives (COCs) are first-line pharmacological treatment for women with PCOS not seeking pregnancy 2

  • COCs suppress ovarian androgen secretion and increase sex hormone binding globulin 2
  • Address menstrual irregularity, hirsutism, and acne
  • Continue lifestyle modifications alongside hormonal therapy 1

Metformin as adjunctive therapy:

  • Improves insulin sensitivity and reduces risk factors for diabetes and cardiovascular disease 2
  • Reduces insulin levels, which decreases ovarian androgen production 3
  • Maintains or improves glucose tolerance over time 3

For Women Attempting Pregnancy

Step 1: Optimize lifestyle first - Weight loss and exercise must be implemented before pharmacological ovulation induction 3

Step 2: Clomiphene citrate is first-line pharmacological treatment for ovulation induction 2, 3, 6

  • Approximately 80% of patients ovulate and half of those who ovulate conceive 2, 3
  • FDA-approved specifically for ovulatory dysfunction in women with PCOS 6
  • Start on or about the 5th day of the cycle 6
  • Limit to about six cycles total (including three ovulatory cycles) 6
  • Use the lowest effective dose to minimize risk of ovarian hyperstimulation syndrome, particularly in PCOS patients who are unusually sensitive to gonadotropin stimulation 6

Step 3: If clomiphene fails, use low-dose gonadotropin therapy due to lower risk of ovarian hyperstimulation compared to higher doses 2

Metformin role in fertility:

  • Improves ovulation frequency and appears safe during pregnancy 3
  • Effects on early pregnancy outcomes not fully established 3
  • Can be used as adjunct to clomiphene 3

Preconception and Pregnancy Management

Before attempting pregnancy:

  • Screen for metabolic abnormalities: fasting glucose, 2-hour glucose tolerance test, and lipid profile 3
  • Provide preconception counseling about increased pregnancy risks 3

During pregnancy:

  • Closer monitoring throughout pregnancy with regular assessment of blood pressure, kidney function, and proteinuria 3
  • Prescribe low-dose aspirin from week 12 to week 36 to reduce preeclampsia risk 3

Long-Term Metabolic Screening and Monitoring

Regular screening for metabolic complications is essential regardless of weight or symptom severity 2

  • Screen for type 2 diabetes mellitus and cardiovascular disease risk factors 2
  • Calculate BMI and waist-hip ratio to assess metabolic risk 2
  • Monitor fasting glucose and lipid profiles 2
  • Assess mental health regularly for depression, anxiety, and eating disorders 2

Critical Pitfalls to Avoid

  • Do not neglect metabolic screening in normal-weight PCOS patients - insulin resistance occurs regardless of BMI 1, 2
  • Do not exceed recommended clomiphene dosage and duration - risk of ovarian hyperstimulation syndrome increases, especially in PCOS patients 2, 6
  • Do not skip pelvic examination before each clomiphene course - must rule out ovarian cysts before treatment 6
  • Do not use clomiphene in patients with ovarian enlargement except those with polycystic ovary syndrome 6
  • Do not delay lifestyle intervention - it must be first-line, not an afterthought 1, 3
  • Watch for visual symptoms with clomiphene - discontinue immediately and perform complete ophthalmological evaluation if visual changes occur 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Polycystic Ovary Syndrome (PCOS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Fertility Management in Women with PCOD

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Lifestyle changes in women with polycystic ovary syndrome.

The Cochrane database of systematic reviews, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.